Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3030
+0.0129 (4.45%)
At close: Sep 18, 2026, 4:00 PM EDT
0.3100
+0.0070 (2.31%)
After-hours: Sep 18, 2026, 7:59 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $48.39 million as of September 18, 2026. Its market cap has decreased by -82.42% in one year.
Market Cap
48.39M
Enterprise Value
19.30M
1-Year Change
-82.42%
Ranking
Category
Stock Price
$0.30
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $48.39M, a decrease of -61.24%. That is a compound annual growth rate of -12.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 48.39M | -27.03% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tevogen | 50.20M |
| Apollomics | 49.47M |
| Elicio Therapeutics | 49.02M |
| Instil Bio | 48.90M |
| Immutep | 47.16M |
| PDS Biotechnology | 47.14M |
| Annovis Bio | 46.87M |
| Werewolf Therapeutics | 46.80M |